A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH

Views
A ...424

Total Visits Per Month

August 2019September 2019October 2019November 2019December 2019January 2020February 2020
A ...11286124132614

File Visits

Views
29FL5e9GFDkgQ.pdf175